跳至主要内容
临床试验/ACTRN12621000377831
ACTRN12621000377831已完成未知

Effect of high-dose fish oil supplementation on arterial inflammation in patients with elevated lipoprotein (a)

The University of Western Australia0 个研究点目标入组 12 人开始时间: 2021年4月1日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
45 Years 至 69 Years(—)
性别
All

入选标准

  • aged between 45-69 years of age with elevated fasting Lp(a) levels (>0.5g/L), stable coronary artery disease and on maximally tolerated doses of lipid-lowering therapy, including a statin, and achieving a fasting LDL-cholesterol of <4.0 mmol/L. Stable coronary artery disease will be defined as previous coronary event (myocardial infarction, stroke, re-vascularisation procedure) >3 months ago or established coronary artery calification (>400) following CT coronary angiogram.

排除标准

  • unstable coronary artery disease or a cardiovascular event within the last 3 months, fasting blood sugar level >7.2 mmol/L, tachyarrhthmias, women who are pregnant or lactating, a previous diagnosis of a severe co-existing medical condition that would prevent participation (eg: severe dementia or terminal illness), <45 or >70 years of age, or unable to provide a written informed consent.

研究者

相似试验